Effect neuromuscular blockade reversal with sugammadex on oxygenation, pain and arousal states in the post-anesthesia care unit - The Neuropa Study

Completed

• Conditions: anesthesie/spierverslapping; anesthesia; muscle relaxation

• Registration Number: NL-OMON40831
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patients, ASA 1-3 undergoing elective general surgery, aged 18+ years, and BMI < 35

Exclusion Criteria

Allergies for NMB agents; neuromuscular disorder; (family) history of malignant hyperthermia; pregnancy/lactating; intestinal obstruction, COPD Gold 4, bradycardia; neuraxial blockade; cognitive dysfunction; pulmonary disease with SpO2 < 94% at baseline; ICU patient post/preoperatively; renal insufficiency.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>SpO2</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Pain score<br /><br>Sedation score<br /><br>Respiratory rate</p><br>